Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -21.81%60.57B | -3.18%77.47B | -15.31%20.27B | -22.39%17.58B | -12.57%16.82B | 60.64%22.81B | 71.74%80.02B | 86.19%23.93B | 83.68%22.65B | 78.36%19.24B |
| Cost of revenue | -7.10%38.25B | 18.62%41.17B | 28.26%12.25B | 32.78%10.52B | -9.96%7.85B | 23.88%10.56B | 14.99%34.71B | 32.87%9.55B | -2.59%7.92B | 20.71%8.71B |
| Gross profit | -38.49%22.33B | -19.88%36.3B | -44.27%8.01B | -52.05%7.06B | -14.73%8.98B | 115.86%12.25B | 176.12%45.31B | 153.85%14.38B | 250.87%14.73B | 194.87%10.53B |
| Operating expense | 32.20%14.71B | 16.93%11.13B | 30.38%4.01B | 17.34%2.48B | 6.12%2.27B | 8.18%2.36B | 19.09%9.51B | 44.24%3.08B | 6.92%2.12B | 10.13%2.14B |
| Staff costs | 39.13%6.38B | 13.07%4.59B | 44.19%1.49B | 4.15%1.11B | 0.71%995M | 2.36%997M | 9.71%4.06B | 14.79%1.03B | 6.85%1.06B | 13.17%988M |
| Depreciation and amortization | 34.51%1.56B | 16.78%1.16B | 35.46%340M | 16.87%291M | 8.50%268M | 6.05%263M | 16.24%995M | 12.05%251M | 12.16%249M | 19.90%247M |
| -Depreciation | 43.86%410M | 23.38%285M | 73.33%104M | 25.86%73M | 0.00%56M | -8.77%52M | 26.92%231M | 17.65%60M | 18.37%58M | 33.33%56M |
| -Amortization | 31.47%1.15B | 14.79%877M | 23.56%236M | 14.14%218M | 10.99%212M | 10.47%211M | 13.35%764M | 10.40%191M | 10.40%191M | 16.46%191M |
| Other operating expenses | 25.79%6.77B | 20.47%5.38B | 21.73%2.19B | 34.82%1.09B | 11.36%1.01B | 14.66%1.1B | 29.88%4.46B | 77.55%1.8B | 5.49%807M | 4.73%907M |
| Operating profit | -69.73%7.62B | -29.67%25.17B | -64.60%4B | -63.70%4.58B | -20.06%6.7B | 182.90%9.89B | 325.12%35.79B | 220.11%11.3B | 468.74%12.61B | 416.00%8.39B |
| Net non-operating interest income (expenses) | -68.77%247M | 3,495.45%791M | 127.50%182M | 3,371.43%243M | 944.83%245M | 436.11%121M | 117.74%22M | 396.30%80M | 123.33%7M | 14.71%-29M |
| Non-operating interest income | -57.75%376M | 446.01%890M | 84.68%205M | 516.28%265M | 3,728.57%268M | 7,500.00%152M | 393.94%163M | 1,133.33%111M | 437.50%43M | 75.00%7M |
| Non-operating interest expense | 30.30%129M | -29.79%99M | -25.81%23M | -38.89%22M | -36.11%23M | -18.42%31M | -10.19%141M | -13.89%31M | -5.26%36M | -5.26%36M |
| Net investment income | 334.94%361M | 132.05%83M | 77.23%-339M | -87.84%84M | -85.62%83M | 771.05%255M | -230.15%-259M | -807.93%-1.49B | 316.27%691M | 1,211.36%577M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 8,185.71%1.16B | -84.27%14M | -86.41%14M | 200.00%14M | 0 | -14M | 4,350.00%89M | 5,050.00%103M | -14M | 0 |
| Income from associates and other participating interests | 0 | 0 | 985.29%369M | |||||||
| Special income (charges) | 202.10%2.43B | -25.24%-2.38B | -44.25%-2.69B | 1,372.22%229M | 256.25%25M | 2,850.00%55M | -288.14%-1.9B | -1,235.37%-1.86B | 96.39%-18M | 91.92%-16M |
| Less:Other special charges | -224.66%-2.94B | 813.18%2.36B | 1,100.45%2.67B | -1,372.22%-229M | -256.25%-25M | -2,850.00%-55M | 188.36%258M | 149.33%222M | -88.75%18M | -61.90%16M |
| Less:Write off | 2,328.57%510M | -98.72%21M | ---- | ---- | ---- | ---- | 632.14%1.64B | ---- | ---- | ---- |
| Other non-operating income (expenses) | 167.50%27M | -433.33%-40M | 54.04%-74M | -94.83%3M | -102.80%-3M | 325.00%34M | -82.35%12M | -7,950.00%-161M | 1,550.00%58M | 167.50%107M |
| Income before tax | -49.93%11.84B | -30.72%23.64B | -86.88%1.09B | -61.36%5.15B | -21.27%7.05B | 195.91%10.34B | 320.97%34.12B | 135.90%8.34B | 620.31%13.33B | 506.43%8.96B |
| Income tax | -63.19%3.13B | -23.95%8.49B | -55.57%1.51B | -60.24%1.52B | -18.61%2.22B | 162.60%3.25B | 314.37%11.16B | 173.81%3.39B | 537.63%3.81B | 477.33%2.73B |
| Net income | -42.50%8.71B | -34.02%15.15B | -108.30%-411M | -61.82%3.64B | -22.43%4.84B | 214.27%7.09B | 324.24%22.96B | 115.35%4.95B | 659.78%9.52B | 520.82%6.23B |
| Net income continuous operations | -42.50%8.71B | -34.02%15.15B | -108.30%-411M | -61.81%3.64B | -22.43%4.83B | 214.18%7.09B | 324.26%22.96B | 115.49%4.95B | 659.78%9.52B | 520.10%6.23B |
| Noncontrolling interests | 109.68%65M | 293.75%31M | -72.73%3M | -22.22%7M | 27.27%14M | 114.89%7M | -206.67%-16M | 175.00%11M | 80.00%9M | 266.67%11M |
| Net income attributable to the company | -42.81%8.65B | -34.21%15.12B | -108.40%-415M | -61.86%3.63B | -22.50%4.82B | 207.51%7.08B | 325.82%22.98B | 115.25%4.94B | 662.18%9.51B | 521.58%6.22B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -42.81%8.65B | -34.21%15.12B | -108.40%-415M | -61.86%3.63B | -22.50%4.82B | 207.51%7.08B | 325.82%22.98B | 115.25%4.94B | 662.18%9.51B | 521.58%6.22B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -37.97%150.026 | -31.60%241.848 | -104.91%-3.73 | -59.31%59.57 | -20.09%76.512 | 209.01%109.496 | 326.21%353.598 | 115.57%76.04 | 662.64%146.382 | 522.43%95.742 |
| Diluted earnings per share | -37.97%150.026 | -31.60%241.848 | -109.16%-6.9626 | -59.34%59.4536 | -20.01%76.512 | 209.01%109.496 | 326.21%353.598 | 115.56%76.0371 | 662.02%146.2316 | 521.85%95.6532 |
| Dividend per share | 30.00%26 | 25.00%20 | 50.00%12 | 0 | 0.00%8 | 0 | 0.00%16 | -50.00%8 | 0 | 8 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |